Additionally, multivariate logistic regression analyses demonstrated that melanoma was higher odds ratio (OR = 4.39), and anti‐PD‐1 monotherapy was lower odds ratio (OR = 0.38; Table 2). Here, PDCD1 is linked to melanoma.